References
- SiegelRMaJZouZJemalACancer statistics, 2014CA Cancer J Clin201464192924399786
- TsaoHAtkinsMBSoberAJManagement of cutaneous melanomaN Engl J Med200435110998101215342808
- MiddletonMRGrobJJAaronsonNRandomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanomaJ Clin Oncol200018115816610623706
- NishioSYamadaNOhyamaHEnhanced suppression of pulmonary metastasis of malignant melanoma cells by combined administration of alpha-galactosylceramide and interleukin-18Cancer Sci20089911312017949451
- OsakiTPeronJMCaiQIFN-gamma-inducing factor/IL-18 administration mediates IFN-gamma- and IL-12-independent antitumor effectsJ Immunol1998160174217499469432
- CoughlinCMSalhanyKEWysockaMInterleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesisJ Clin Invest19981016144114529502787
- NagaiHHaraIHorikawaTOkaMKamidonoSIchihashiMGene transfer of secreted-type modified interleukin-18 gene to B16F10 melanoma cells suppresses in vivo tumor growth through inhibition of tumor vessel formationJ Invest Dermatol20001193541548
- TianHShiGYangGCellular immunotherapy using irradiated lung cancer cell vaccine co-expressing GM-CSF and IL-18 can induce significant antitumor effectsBMC Cancer2014144824475975
- DorerDEHoltrupFFellenbergKReplication and virus induced transcriptome of HAdV-5 in normal host cells versus cancer cells: differences of relevance for adenoviral oncolysisPLoS ONE2011611e2793422140489
- ZhengJNPeiDSMaoLJOncolytic adenovirus expressing interleukin-18 induces significant antitumor effects against melanoma in mice through inhibition of angiogenesisCancer Gene Ther2010171283619498459
- MayerJESwetterSMFuTGellerACScreening, early detection, education, and trends for melanoma: current status (2007–2013) and future directions: part I. Epidemiology, high-risk groups, clinical strategies, and diagnostic technologyJ Am Acad Dermatol2014714599.e1599.e1225219716
- ChangAEKarnellLHMenckHRThe National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer SocietyCancer1998838166416789781962
- QuirinCMainkaAHesseANettelbeckDMCombining adenoviral oncolysis with temozolomide improves cell killing of melanoma cellsInt J Cancer2007121122801280717724714
- LillehammerTEngesaeterBOPrasmickaiteLMaelandsmoGMFodstadOEngebraatenOCombined treatment with Ad-hTRAIL and DTIC or SAHA is associated with increased mitochondrial-mediated apoptosis in human melanoma cell linesJ Gene Med20079644045117410615
- LooTLHousholderGEGerulathAHSaundersPHFarquharDMechanism of action and pharmacology studies with DTIC (NSC-45388)Cancer Treat Rep19766021491521260772
- EggermontAMKirkwoodJMRe-evaluating the role of dacarbazine in metastatic melanoma: what have we learned in 30 years?Eur J Cancer200440121825183615288283
- RedondoPSánchez-CarpinteroIBauzáAIdoateMSolanoTMihmMCJrImmunologic escape and angiogenesis in human malignant melanomaJ Am Acad Dermatol200349225526312894074
- FolkmanJWhat is the evidence that tumors are angiogenesis dependent?J Natl Cancer Inst1990821461688381
- RofstadEKHalsørEFVascular endothelial growth factor, interleukin 8, platelet-derived endothelial cell growth factor, and basic fibroblast growth factor promote angiogenesis and metastasis in human melanoma xenograftsCancer Res200060174932493810987309
- DrevsJHofmannIHugenschmidtHEffects of PTK787/ZK 222584, a specific inhibitor of vascular endothelial growth factor receptor tyrosine kinases, on primary tumor, metastasis, vessel density, and blood flow in a murine renal cell carcinoma modelCancer Res200060174819482410987292
- CaoRFarneboJKurimotoMCaoYInterleukin-18 acts as an angiogenesis and tumor suppressorFASEB J199913152195220210593867